Experts in regulatory science have called for a coherent and specific national strategy for regulatory science in the UK, including training, funding and cross-disciplinary working, in a new report.
“Advancing regulatory science and innovation in healthcare”, published by the Centre for Regulatory Science and Innovation on behalf of Birmingham Health Partners (BHP), examines the UK’s ability to adapt its regulatory frameworks in healthcare in response to innovation through the lens of Brexit and the COVID-19 pandemic. It suggests that a coordinated approach should be taken to foster and prioritise innovation in regulatory science and build a corresponding workforce to ensure its sustainability and continuing evolution.
The report was put together with expert input and support from a wide range of stakeholders, including TOPRA.
Jenine Willis, TOPRA’s Director of Communications, said: “As a regulatory affairs professional body and leading provider in training for the profession, we are delighted to see this report, which showcases the importance of regulatory science, particularly during these unprecedented times.”